KR100886578B1 - 카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물 - Google Patents

카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물 Download PDF

Info

Publication number
KR100886578B1
KR100886578B1 KR1020037011292A KR20037011292A KR100886578B1 KR 100886578 B1 KR100886578 B1 KR 100886578B1 KR 1020037011292 A KR1020037011292 A KR 1020037011292A KR 20037011292 A KR20037011292 A KR 20037011292A KR 100886578 B1 KR100886578 B1 KR 100886578B1
Authority
KR
South Korea
Prior art keywords
formula
group
schizophrenia
delete delete
enantiomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
KR1020037011292A
Other languages
English (en)
Korean (ko)
Other versions
KR20030076713A (ko
Inventor
플라타-살라먼칼로스알.
자오보위
트와이먼로이이.
Original Assignee
오르토-맥네일 파마슈티칼, 인코퍼레이티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오르토-맥네일 파마슈티칼, 인코퍼레이티드 filed Critical 오르토-맥네일 파마슈티칼, 인코퍼레이티드
Publication of KR20030076713A publication Critical patent/KR20030076713A/ko
Application granted granted Critical
Publication of KR100886578B1 publication Critical patent/KR100886578B1/ko
Assigned to 에스케이바이오팜 주식회사 reassignment 에스케이바이오팜 주식회사 권리의 전부이전등록 Assignors: 얀센 파마슈티칼즈, 인코포레이티드
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020037011292A 2001-02-27 2002-02-21 카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물 Expired - Lifetime KR100886578B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US27188901P 2001-02-27 2001-02-27
US60/271,889 2001-02-27
US10/081,761 2002-02-21
US10/081,761 US6541513B2 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders
PCT/US2002/006119 WO2002067927A1 (en) 2001-02-27 2002-02-21 Carbamate compounds for use in preventing or treating psychotic disorders

Publications (2)

Publication Number Publication Date
KR20030076713A KR20030076713A (ko) 2003-09-26
KR100886578B1 true KR100886578B1 (ko) 2009-03-05

Family

ID=26765939

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020037011292A Expired - Lifetime KR100886578B1 (ko) 2001-02-27 2002-02-21 카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물

Country Status (25)

Country Link
US (1) US6541513B2 (https=)
EP (1) EP1401424B1 (https=)
JP (1) JP4276841B2 (https=)
KR (1) KR100886578B1 (https=)
CN (1) CN1262271C (https=)
AR (1) AR032876A1 (https=)
AT (1) ATE346597T1 (https=)
AU (1) AU2002242296B2 (https=)
BR (1) BR0207829A (https=)
CA (1) CA2439480C (https=)
CZ (1) CZ302412B6 (https=)
DE (1) DE60216457T2 (https=)
DK (1) DK1401424T3 (https=)
ES (1) ES2275844T3 (https=)
HU (1) HUP0303342A3 (https=)
IL (2) IL157588A0 (https=)
MX (1) MXPA03007722A (https=)
NO (1) NO20033801L (https=)
NZ (1) NZ527991A (https=)
PL (1) PL365021A1 (https=)
PT (1) PT1401424E (https=)
RS (1) RS51056B (https=)
RU (1) RU2302240C2 (https=)
TW (1) TWI251486B (https=)
WO (1) WO2002067927A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014142550A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
US9682059B2 (en) 2013-03-12 2017-06-20 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE267629T1 (de) * 2000-07-21 2004-06-15 Ortho Mcneil Pharm Inc Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen
EP1383489B1 (en) * 2001-02-27 2007-05-09 Ortho-Mcneil Pharmaceutical, Inc. Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157594A0 (en) 2001-02-27 2004-03-28 Ortho Mcneil Pharm Inc Carbamate compounds for use in preventing or treating anxiety disorders
ATE435014T1 (de) 2001-07-16 2009-07-15 Ortho Mcneil Pharm Inc Carbamate verbindungen zur vorbeugung oder behandlung von neuropathischen schmerzen
EP1744750A2 (en) * 2004-05-06 2007-01-24 Sandoz AG Pharmaceutical composition comprising hydrophobic drug having improved solubility
ES2385087T3 (es) * 2005-07-26 2012-07-18 Sk Biopharmaceuticals Co., Ltd Procedimientos para tratar trastornos relacionados con sustancias
EP2081648A2 (en) * 2006-10-30 2009-07-29 Janssen Pharmaceutica, N.V. Carbamate compounds for use in treating depression
BRPI0718323A2 (pt) * 2006-10-31 2013-11-26 Janssen Pharmaceutica Nv Tratamento de transtornos invasivos do desenvolvimento.
US8609849B1 (en) 2010-11-30 2013-12-17 Fox Chase Chemical Diversity Center, Inc. Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
KR102900173B1 (ko) * 2016-12-14 2025-12-12 에스케이바이오팜 주식회사 조현병, 강박장애 및 투렛증후군으로부터 선택되는 정신증 장애의 예방, 경감 또는 치료에 있어서의 카바메이트 화합물의 용도

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US278380A (en) * 1883-05-29 Thermometer
US3313692A (en) * 1958-04-21 1967-04-11 Armour Pharma Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) * 1962-07-18 1966-08-09 Armour Pharma Substituted phenethyl carbamates
CA2051697C (en) * 1989-06-09 1996-10-08 Malcolm Wilson Moon Heterocyclic amines having central nervous system activity
US5492930A (en) * 1994-04-25 1996-02-20 Schering Corporation Method and formulation for treating CNS disorders

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6103759A (en) * 1996-01-16 2000-08-15 Sk Corporation Halogen substituted carbamate compounds from 2-phenyl-1, 2-ethanediol

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014142550A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
WO2014142547A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same
WO2014142548A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
WO2014142549A1 (en) * 2013-03-12 2014-09-18 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
US9457003B2 (en) 2013-03-12 2016-10-04 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a nerve gas-induced disease comprising the same
US9566261B2 (en) 2013-03-12 2017-02-14 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a memory loss-related disease comprising the same
KR101739677B1 (ko) 2013-03-12 2017-05-24 (주)바이오팜솔루션즈 페닐카바메이트 화합물 및 이를 포함하는 정신 질환의 예방 또는 치료용 조성물
US9682059B2 (en) 2013-03-12 2017-06-20 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating epilepsy or epilepsy-related syndrome
US9872847B2 (en) 2013-03-12 2018-01-23 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compounds for use in preventing or treating a movement disorder
US9907776B2 (en) 2013-03-12 2018-03-06 Bio-Pharm Solutions, Co., Ltd. Phenyl carbamate compound and a composition for preventing or treating a psychiatric disorder comprising the same
US10525030B2 (en) 2013-03-12 2020-01-07 Bio-Pharm Solutions Co., Ltd. Phenyl carbamate compound and a composition for neuroprotection comprising the same

Also Published As

Publication number Publication date
TWI251486B (en) 2006-03-21
NZ527991A (en) 2005-04-29
HUP0303342A2 (hu) 2004-01-28
EP1401424A1 (en) 2004-03-31
ATE346597T1 (de) 2006-12-15
DE60216457D1 (de) 2007-01-11
DE60216457T2 (de) 2007-09-20
NO20033801L (no) 2003-10-22
EP1401424B1 (en) 2006-11-29
RS67503A (sr) 2006-12-15
CA2439480A1 (en) 2002-09-06
RU2302240C2 (ru) 2007-07-10
PT1401424E (pt) 2007-02-28
IL157588A0 (en) 2004-03-28
US20020165272A1 (en) 2002-11-07
CZ20032297A3 (cs) 2004-06-16
CN1262271C (zh) 2006-07-05
MXPA03007722A (es) 2004-11-12
CA2439480C (en) 2011-04-26
KR20030076713A (ko) 2003-09-26
DK1401424T3 (da) 2007-02-26
BR0207829A (pt) 2004-06-22
WO2002067927A1 (en) 2002-09-06
PL365021A1 (en) 2004-12-27
JP4276841B2 (ja) 2009-06-10
ES2275844T3 (es) 2007-06-16
IL157588A (en) 2009-12-24
US6541513B2 (en) 2003-04-01
AR032876A1 (es) 2003-11-26
RS51056B (sr) 2010-10-31
NO20033801D0 (no) 2003-08-26
JP2004523556A (ja) 2004-08-05
RU2003128983A (ru) 2005-03-10
CN1505507A (zh) 2004-06-16
AU2002242296B2 (en) 2006-06-29
CZ302412B6 (cs) 2011-05-04
HUP0303342A3 (en) 2012-07-30

Similar Documents

Publication Publication Date Title
KR101783632B1 (ko) 주의력 결핍/과잉행동 장애(ａｄｈｄ)의 치료 방법
KR101335941B1 (ko) 수면-각성 장애의 치료
KR100886578B1 (ko) 카바메이트 화합물을 포함하는 정신증 장애 예방용 또는 치료용 약제학적 조성물
KR20030074847A (ko) 거동 장애 예방 또는 치료용 카바메이트 화합물
HK1247847A1 (zh) 四氢-N，N-二甲基-2，2-二苯基-3-呋喃甲胺的对映体(ANAVEX2-73)及其在治疗阿尔海默氏病和其他由σ1受体调节的疾病中的用途
KR20080089405A (ko) 신경보호제로써 벤조-융합된 헤테로사이클 설파미드유도체의 용도
TWI250872B (en) Carbamate compounds for use in preventing or treating bipolar disorder
AU2002242296A1 (en) Carbamate compounds for use in preventing or treating psychotic disorders
KR20080089414A (ko) 우울증 치료를 위한 벤조-융합된 헤테로사이클 설파미드유도체의 용도
KR101199499B1 (ko) 물질 관련 장애를 치료하는 방법
US20230201150A1 (en) The combination of acetyl leucine and 4-aminopyridine or acetazolamide for treating ataxia
ZA200307469B (en) Carbamate compounds for use in preventing or treating psychotic disorders.
WO2024226995A1 (en) Compositions and methods for treating post-traumatic stress disorder
Kertész et al. P. 1. c. 044 Improvement of AMPA antagonist activity by methyl substitution on the aniline ring of 2, 3-benzodiazepine derivatives
HK1209058B (en) Compositions for treating drug addiction and improving addiction-related behavior
HK1209058A1 (en) Compositions for treating drug addiction and improving addiction-related behavior

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20030827

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20070220

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20080324

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20081126

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20090225

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20090226

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
PR1001 Payment of annual fee

Payment date: 20111215

Start annual number: 4

End annual number: 4

FPAY Annual fee payment

Payment date: 20130111

Year of fee payment: 5

PR1001 Payment of annual fee

Payment date: 20130111

Start annual number: 5

End annual number: 5

FPAY Annual fee payment

Payment date: 20140122

Year of fee payment: 6

PR1001 Payment of annual fee

Payment date: 20140122

Start annual number: 6

End annual number: 6

FPAY Annual fee payment

Payment date: 20150128

Year of fee payment: 7

PR1001 Payment of annual fee

Payment date: 20150128

Start annual number: 7

End annual number: 7

FPAY Annual fee payment

Payment date: 20160122

Year of fee payment: 8

PR1001 Payment of annual fee

Payment date: 20160122

Start annual number: 8

End annual number: 8

FPAY Annual fee payment

Payment date: 20170106

Year of fee payment: 9

PR1001 Payment of annual fee

Payment date: 20170106

Start annual number: 9

End annual number: 9

FPAY Annual fee payment

Payment date: 20171213

Year of fee payment: 10

PR1001 Payment of annual fee

Payment date: 20171213

Start annual number: 10

End annual number: 10

FPAY Annual fee payment

Payment date: 20181227

Year of fee payment: 11

PR1001 Payment of annual fee

Payment date: 20181227

Start annual number: 11

End annual number: 11

FPAY Annual fee payment

Payment date: 20200108

Year of fee payment: 12

PR1001 Payment of annual fee

Payment date: 20200108

Start annual number: 12

End annual number: 12

PR1001 Payment of annual fee

Payment date: 20210104

Start annual number: 13

End annual number: 13

PC1801 Expiration of term

Termination date: 20220821

Termination category: Expiration of duration